Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SUMICHEM.NS Stock Summary
Top 10 Correlated ETFs
SUMICHEM.NS
In the News
SUMICHEM.NS Financial details
Company Rating
Buy
Market Cap
201.23B
Income
3.32B
Revenue
28.2B
Book val./share
-
Cash/share
-
Dividend
1.2
Dividend %
0.29%
Employees
1.64K
Optionable
No
Shortable
Yes
Earnings
16 May 2024
P/E
55.45
Forward P/E
-
PEG
-25.73
P/S
6.72
P/B
8.07
P/C
-
P/FCF
-
Quick Ratio
2.41
Current Ratio
3.11
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
6.66
EPS next Y
-
EPS next Q
-
EPS this Y
18.49%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
24.82%
Revenue last 5Y
9.97%
Revenue Q/Q
-40.01%
EPS Q/Q
-61.67%
-
-
-
-
SMA20
12.03%
SMA50
-2.01%
SMA100
1.03%
Inst Own
-
Inst Trans
-
ROA
10%
ROE
30%
ROC
0.18%
Gross Margin
34%
Oper. Margin
15%
Profit Margin
12%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
336.1-454.9
52W High
-14.27%
52W Low
+15.83%
RSI
60
Rel Volume
0.39
Avg Volume
351.79K
Volume
138.4K
Perf Week
-0.37%
Perf Month
3.4%
Perf Quarter
2.5%
Perf Half Y
-7.31%
-
-
-
-
Beta
0.411
-
-
Volatility
6.92%, 19.45%
Prev Close
0%
Price
389.2
Change
-0.47%
SUMICHEM.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 43.73 | 48.03 | 52.64 | 60.91 | 70.34 | |
Net income per share | 3.32 | 4.1 | 6.92 | 8.49 | 10.06 | |
Operating cash flow per share | 1.56 | 4.44 | 8.52 | 4.44 | 7.8 | |
Free cash flow per share | 0.76 | 3.67 | 7.66 | 2.17 | 5.4 | |
Cash per share | 1.02 | 3.58 | 10.66 | 11.53 | 16.56 | |
Book value per share | 21 | 24.48 | 30.88 | 38.61 | 47.72 | |
Tangible book value per share | 20.86 | 24.37 | 30.67 | 38.24 | 47.29 | |
Share holders equity per share | 21 | 24.48 | 30.88 | 38.61 | 47.72 | |
Interest debt per share | 0.47 | 0.82 | 0.74 | 0.85 | 0.79 | |
Market cap | 100.18B | 92.19B | 145.1B | 223.87B | 212.69B | |
Enterprise value | 99.87B | 91.62B | 143.29B | 223.67B | 212.56B | |
P/E ratio | 60.42 | 45.04 | 42.02 | 52.85 | 42.35 | |
Price to sales ratio | 4.59 | 3.85 | 5.52 | 7.36 | 6.06 | |
POCF ratio | 128.95 | 41.64 | 34.11 | 100.94 | 54.62 | |
PFCF ratio | 263.96 | 50.27 | 37.97 | 206.78 | 78.92 | |
P/B Ratio | 9.56 | 7.55 | 9.41 | 11.62 | 8.93 | |
PTB ratio | 9.56 | 7.55 | 9.41 | 11.62 | 8.93 | |
EV to sales | 4.58 | 3.82 | 5.45 | 7.36 | 6.05 | |
Enterprise value over EBITDA | 34.16 | 26.64 | 27.71 | 36.66 | 29.88 | |
EV to operating cash flow | 128.56 | 41.38 | 33.68 | 100.85 | 54.59 | |
EV to free cash flow | 263.15 | 49.96 | 37.5 | 206.6 | 78.87 | |
Earnings yield | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Free cash flow yield | 0 | 0.02 | 0.03 | 0 | 0.01 | |
Debt to equity | 0.02 | 0.03 | 0.02 | 0.02 | 0.01 | |
Debt to assets | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | |
Net debt to EBITDA | -0.11 | -0.17 | -0.35 | -0.03 | -0.02 | |
Current ratio | 1.99 | 2.08 | 2.14 | 2.47 | 2.99 | |
Interest coverage | 73.61 | 53.85 | 108.27 | 117.98 | 113.99 | |
Income quality | 0.3 | 0.83 | 0.94 | 0.39 | 0.6 | |
Dividend Yield | 0.01 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.36 | 0.11 | 0.08 | 0.09 | 0.1 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0.01 | 0.01 | |
Capex to operating cash flow | -0.51 | -0.17 | -0.1 | -0.51 | -0.31 | |
Capex to revenue | -0.02 | -0.02 | -0.02 | -0.04 | -0.03 | |
Capex to depreciation | -1.43 | -0.93 | -0.93 | -2.53 | -2.31 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 39.62 | 47.52 | 69.33 | 85.86 | 103.93 | |
ROIC | 0.16 | 0.18 | 0.21 | 0.2 | 0.19 | |
Return on tangible assets | 0.09 | 0.1 | 0.13 | 0.14 | 0.15 | |
Graham Net | 1.96 | 4.56 | 8.37 | 11.99 | 19.98 | |
Working capital | 7.65B | 9.06B | 12.25B | 15.01B | 18.55B | |
Tangible asset value | 10.41B | 12.16B | 15.31B | 19.09B | 23.6B | |
Net current asset value | 7.3B | 8.61B | 11.76B | 14.4B | 18.01B | |
Invested capital | 0.02 | 0.03 | 0.02 | 0.02 | 0.01 | |
Average receivables | 6.76B | 7.72B | 8.51B | 8.49B | 9B | |
Average payables | 5.62B | 5.44B | 5.45B | 5.58B | 5.04B | |
Average inventory | 6.45B | 6.34B | 6.71B | 8.46B | 9.13B | |
Days sales outstanding | 115.51 | 129.73 | 117.99 | 101.9 | 98.93 | |
Days payables outstanding | 148.64 | 111.04 | 131.43 | 98.49 | 78.87 | |
Days of inventory on hand | 169.52 | 132.99 | 165.7 | 178.58 | 142.86 | |
Receivables turnover | 3.16 | 2.81 | 3.09 | 3.58 | 3.69 | |
Payables turnover | 2.46 | 3.29 | 2.78 | 3.71 | 4.63 | |
Inventory turnover | 2.15 | 2.74 | 2.2 | 2.04 | 2.56 | |
ROE | 0.16 | 0.17 | 0.22 | 0.22 | 0.21 | |
Capex per share | -0.8 | -0.76 | -0.87 | -2.27 | -2.4 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 15.1 | 13.02 | 14.51 | 18.1 | 10.86 | |
Net income per share | 1.81 | 1.45 | 1.24 | 2.87 | 1.1 | |
Operating cash flow per share | 0.46 | 0.56 | 0.54 | 0.63 | 0.65 | |
Free cash flow per share | 0.46 | 0.56 | 0.54 | 0.63 | 0.65 | |
Cash per share | 14.52 | 16.56 | 16.02 | 28.19 | 0 | |
Book value per share | 44.47 | 47.72 | 47.72 | 50.61 | 0 | |
Tangible book value per share | 0 | 47.29 | 0 | 50.14 | 0 | |
Share holders equity per share | 44.47 | 47.72 | 47.72 | 50.61 | 0 | |
Interest debt per share | 0.03 | 0.71 | 0.03 | 0.61 | 0.02 | |
Market cap | 243.68B | 212.69B | 217.78B | 210.84B | 204.72B | |
Enterprise value | 250.93B | 212.56B | 225.77B | 210.62B | 204.72B | |
P/E ratio | 67.33 | 73.72 | 88.27 | 36.75 | 93.54 | |
Price to sales ratio | 32.33 | 32.71 | 30.07 | 23.34 | 37.77 | |
POCF ratio | 1.07K | 757.64 | 805.03 | 668.4 | 635.08 | |
PFCF ratio | 1.07K | 757.64 | 805.03 | 668.4 | 635.08 | |
P/B Ratio | 10.98 | 8.93 | 9.14 | 8.35 | 0 | |
PTB ratio | 10.98 | 8.93 | 9.14 | 8.35 | 0 | |
EV to sales | 33.3 | 32.69 | 31.17 | 23.31 | 37.77 | |
Enterprise value over EBITDA | 187.81 | 219.01 | 280 | 99.11 | 220.88 | |
EV to operating cash flow | 1.1K | 757.18 | 834.59 | 667.71 | 635.08 | |
EV to free cash flow | 1.1K | 757.18 | 834.59 | 667.71 | 635.08 | |
Earnings yield | 0 | 0 | 0 | 0.01 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0.01 | 0 | 0.01 | 0 | |
Debt to assets | 0 | 0.01 | 0 | 0.01 | 0 | |
Net debt to EBITDA | 5.42 | -0.13 | 9.92 | -0.1 | 0 | |
Current ratio | 0 | 2.99 | 0 | 3.11 | 0 | |
Interest coverage | 93.15 | 47.87 | 50.23 | 158.15 | 62.92 | |
Income quality | 0.25 | 0.39 | 0.44 | 0.22 | 0.59 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.09 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.01 | 0 | 0.01 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 42.59 | 39.39 | 36.42 | 57.2 | 0 | |
ROIC | 0.04 | 0.02 | 0.02 | 0.06 | 0 | |
Return on tangible assets | 0 | 0.02 | 0 | 0.04 | 0 | |
Graham Net | 14.52 | 19.98 | 16.02 | 26.79 | 0 | |
Working capital | 7.25B | 18.55B | 7.99B | 19.97B | 0 | |
Tangible asset value | 0 | 23.6B | 0 | 25.03B | 0 | |
Net current asset value | 7.25B | 18.01B | 7.99B | 19.4B | 0 | |
Invested capital | 0 | 0.01 | 0 | 0.01 | 0 | |
Average receivables | 5.93B | 4.76B | 4.76B | 4.34B | 4.34B | |
Average payables | 2.75B | 2.45B | 2.45B | 2.2B | 2.2B | |
Average inventory | 4.09B | 4.44B | 4.44B | 2.81B | 2.81B | |
Days sales outstanding | 0 | 131.74 | 0 | 86.53 | 0 | |
Days payables outstanding | 0 | 98.69 | 0 | 71.08 | 0 | |
Days of inventory on hand | 0 | 178.76 | 0 | 90.76 | 0 | |
Receivables turnover | 0 | 0.68 | 0 | 1.04 | 0 | |
Payables turnover | 0 | 0.91 | 0 | 1.27 | 0 | |
Inventory turnover | 0 | 0.5 | 0 | 0.99 | 0 | |
ROE | 0.04 | 0.03 | 0.03 | 0.06 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
SUMICHEM.NS Frequently Asked Questions
What is Sumitomo Chemical India Limited stock symbol ?
Sumitomo Chemical India Limited is a IN stock and trading under the symbol SUMICHEM.NS
What is Sumitomo Chemical India Limited stock quote today ?
Sumitomo Chemical India Limited stock price is $389.2 today.
Is Sumitomo Chemical India Limited stock public?
Yes, Sumitomo Chemical India Limited is a publicly traded company.